Prof. Dr. med
Viola Heinzelmann
Universitätsspital Basel
Optimizing Ovarian Cancer Treatment
Quickfacts
- October 7, 2025
- 18:00–20:00
- Zoom
- English
- Oncology
- Credits requested: SGAIM | SGGG | SGMO | SRO
Expert Perspectives on the Evolution of Standards
The treatment of ovarian cancer is rapidly evolving thanks to biomarkers, targeted therapies, and maintenance approaches. This free webinar brings together renowned experts to discuss recent advances and their impact on clinical practice through presentations and real-life case studies.
| 18:00 18:05 | Welcome & Opening RemarksProf. Isabell Witzel |
| 18:05 18:25 | Introduction: Treatment Decisions in Ovarian Cancer: Surgery or Neoadjuvant Therapy FirstProf. Viola Heinzelmann |
| 18:25 18:45 | Presentation 1: First-Line Ovarian Cancer – Treatment Evolution & Future Options (incl. IO combinations, stratification)Prof. Isabelle Ray-Coquard |
| 18:45 18:50 | Case studyDr. Marta Nerone |
| 18:50 19:10 | Discussion & Q&A (Roundtable, interactive)Prof. Isabelle Ray-Coquard |
| 19:10 19:30 | Presentation 2: Second-Line/Recurrent Setting – Biomarkers and Novel Agents (incl. HER2, BRCA, FRα)Prof. Isabelle Ray-Coquard |
| 19:30 19:35 | Case studyProf. Viola Heinzelmann |
| 19:35 19:55 | Discussion & Q&A (Roundtable, interactive) |
| 19:55 20:00 | Closing RemarksProf. Isabell Witzel |
Experts
Prof. Dr. med
Dr.ssa med.
Marta Nerone
Istituto Oncologico della Svizzera Italiana
Prof.
Isabelle Ray-Coquard
Centre Léon Bérard
Prof. Dr. med.
Isabell Witzel
Universitätsspital Zürich
